Phase 3 Study Data Shows Obeticholic Acid Could Treat NASH-Linked Fibrosis
According to a press release from American biotechnology company Intercept Pharmaceuticals, the company recently released additional data supporting its phase 3 clinical trial of obeticholic acid (OCA) in the treatment…